MetaCap

Bruker Corporation Company Profile

NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

59.72-0.78 (-1.29%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Bruker at a glance

Bruker Corporation (NASDAQ: BRKR) is a Biotechnology: Laboratory Analytical Instruments company in the Industrials sector headquartered in Billerica, MA. Bruker is led by Dr. Frank H. Laukien Ph.D. and employs about 11,085 people. At a market capitalization of $9.22 billion, it is considered a mid-cap company.

Its SEC Central Index Key (CIK) is 0001109354, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Bruker do?

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Bruker Corporation
Ticker
NASDAQ: BRKR
Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Dr. Frank H. Laukien Ph.D.
Employees
11,085
Headquarters
40 Manning Road, Billerica, MA, United States
Phone
978 663 3660
Website
bruker.com
SEC CIK
0001109354

Companies similar to Bruker

BRKR peer companies
CompanyPrice% ChgMarket capCompare
BIOBio-Rad Laboratories Inc. Class A367.92-0.25%$9.84Bvs BRKR
TXG10x Genomics Inc. Class A76.10-5.65%$9.92Bvs BRKR
AVTRAvantor Inc.15.35-0.52%$10.38Bvs BRKR
ALMRAlamar Biosciences Inc.27.77-13.92%$1.93Bvs BRKR
CIRCCircle8 Group Inc.0.46-7.26%$52.63Mvs BRKR
RPIDRapid Micro Biosystems Inc. Class A0.8977-4.76%$45.03Mvs BRKR
PRPOPrecipio Inc.23.52+0.30%$42.11Mvs BRKR
HBIOHarvard Bioscience Inc.8.50-0.70%$38.69Mvs BRKR

Related